Abstract
Patients undergoing treatment of acute lymphoblastic leukemia (ALL) are at risk for thrombosis, caused in part by the use of L-asparaginase (L-ASP). A......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
